GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $749,000 | -53.1% | 17,200 | -53.1% | 0.09% | -48.0% |
| Q1 2022 | $1,598,000 | +207.3% | 36,700 | +211.0% | 0.18% | +645.8% |
| Q4 2021 | $520,000 | +83.7% | 11,800 | +15845.9% | 0.02% | +9.1% |
| Q3 2021 | $283,000 | -50.6% | 74 | -99.5% | 0.02% | -53.2% |
| Q2 2021 | $573,000 | -5.6% | 14,400 | +43.0% | 0.05% | -28.8% |
| Q1 2021 | $607,000 | -70.8% | 10,070 | -54.2% | 0.07% | -62.3% |
| Q4 2020 | $2,078,000 | +16.0% | 21,998 | +39.9% | 0.18% | -6.9% |
| Q3 2020 | $1,792,000 | +158.6% | 15,722 | +201.2% | 0.19% | +118.6% |
| Q2 2020 | $693,000 | +82.8% | 5,219 | +5119.0% | 0.09% | +28.4% |
| Q1 2020 | $379,000 | -89.1% | 100 | -99.8% | 0.07% | -74.4% |
| Q4 2019 | $3,468,000 | +929.1% | 42,318 | +53467.1% | 0.26% | +773.3% |
| Q3 2019 | $337,000 | -65.3% | 79 | -99.5% | 0.03% | -73.5% |
| Q2 2019 | $972,000 | +330.1% | 16,479 | +30416.7% | 0.11% | +175.6% |
| Q1 2019 | $226,000 | -11.7% | 54 | -99.2% | 0.04% | +86.4% |
| Q4 2018 | $256,000 | -57.8% | 6,700 | -55.6% | 0.02% | -90.3% |
| Q3 2018 | $607,000 | +142.8% | 15,100 | +143.5% | 0.23% | +527.8% |
| Q2 2018 | $250,000 | -50.0% | 6,200 | -51.6% | 0.04% | -70.5% |
| Q1 2018 | $500,000 | +124.2% | 12,800 | +24050.9% | 0.12% | +90.6% |
| Q1 2017 | $223,000 | +7.7% | 53 | -98.9% | 0.06% | -8.6% |
| Q3 2016 | $207,000 | +2487.5% | 4,800 | +20769.6% | 0.07% | +1066.7% |
| Q3 2015 | $8,000 | -88.1% | 23 | -98.6% | 0.01% | -81.8% |
| Q2 2015 | $67,000 | -57.3% | 1,600 | -53.4% | 0.03% | -72.0% |
| Q1 2015 | $157,000 | -39.1% | 3,433 | -41.4% | 0.12% | +59.5% |
| Q4 2014 | $258,000 | -40.0% | 5,860 | -36.8% | 0.07% | -40.8% |
| Q3 2014 | $430,000 | +38.7% | 9,278 | +60.0% | 0.12% | +17.9% |
| Q2 2014 | $310,000 | +115.3% | 5,800 | +114.8% | 0.11% | +23.3% |
| Q1 2014 | $144,000 | +125.0% | 2,700 | +123.0% | 0.09% | +681.8% |
| Q4 2013 | $64,000 | +113.3% | 1,211 | +99.8% | 0.01% | +10.0% |
| Q3 2013 | $30,000 | -97.8% | 606 | -97.8% | 0.01% | -98.5% |
| Q2 2013 | $1,367,000 | – | 27,371 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |